Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | PRNP | P04156 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16702735 | 0.82 | NQO2 (0.42) | NQO2LMNAALDH1A1PRNPNPSR1 | |
| SCHEMBL24421891 | 0.72 | LMNA (0.44) | NQO2LMNAALDH1A1PRNPNPSR1 | |
| SCHEMBL27896649 | 0.72 | NQO2 (0.37) | NQO2LMNAALDH1A1PRNPNPSR1 | |
| SCHEMBL17006829 | 0.71 | LMNA (0.42) | LMNA | |
| SCHEMBL2832398 | 0.69 | NQO2 (0.34) | NQO2LMNAPRNPNPSR1HPGD | |
| SCHEMBL3874742 | 0.67 | MAPT (0.38) | NQO2LMNAALDH1A1HPGDMAPT | |
| SCHEMBL4597901 | 0.65 | LMNA (0.42) | LMNAALDH1A1 | |
| SCHEMBL13035870 | 0.63 | LMNA (0.41) | LMNA | |
| SCHEMBL31336324 | 0.63 | LMNA (0.36) | LMNA | |
| SCHEMBL26608186 | 0.63 | LMNA (0.36) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3504216-A1 | 1,3-DITHIOLO[5,6-F]BENZO-2,1,3-THIADIAZOLE OR 1,3-DITHIOLO[6,7-G]QUINOXALINE BASED ORGANIC SEMICONDUCTORS | Merck Patent GmbH (DE) | 2019-07-03 | — | — | EP | disclosed |
| US-20190189925-A1 | ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2019-06-20 | — | — | US | disclosed |
| US-20190189925-A1 | ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2019-06-20 | — | — | US | disclosed |
| WO-2018041768-A1 | 1,3-DITHIOLO[5,6-F]BENZO-2,1,3-THIADIAZOLE OR 1,3-DITHIOLO[6,7-G]QUINOXALINE BASED ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2018-03-08 | — | — | WO | disclosed |
| WO-2018041768-A1 | 1,3-DITHIOLO[5,6-F]BENZO-2,1,3-THIADIAZOLE OR 1,3-DITHIOLO[6,7-G]QUINOXALINE BASED ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2018-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190189925-A1 | ORGANIC SEMICONDUCTORS | OCIAD2, OCIAD1, OSTC | NQO2 930/4885LMNA 4837/4885ALDH1A1 2067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.